ItalyOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 750 out of 116,246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 139,750 | 141,579 |
| Total Cites | 612 | 686 |
| H-index | 13 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 53 | 56 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 153 | 163 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 469 | 509 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
10.79%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 595 out of 105,572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100,566 | 106,450 |
| Total Cites | 886 | 998 |
| H-index | 15 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 69 | 72 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 204 | 229 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 660 | 698 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.43 |
| Self-Citation Percentage |
11.22%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 569 out of 101,860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98,061 | 94,321 |
| Total Cites | 1,225 | 1,451 |
| H-index | 18 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 97 | 106 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 282 | 343 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 915 | 1,000 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.45 |
| Self-Citation Percentage |
15.58%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 523 out of 84,246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91,708 | 78,704 |
| Total Cites | 871 | 1,054 |
| H-index | 15 | 18 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 79 | 89 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 202 | 277 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 656 | 722 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.46 |
| Self-Citation Percentage |
17.36%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Italy7,991 scientists, 7th in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.